Skip to main content
OpenTrials

Clinical trial condition

Lymphoproliferative Disorders

Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,144 public trials 2,036 recruiting studies
Refine in advanced search Browse all conditions

Lymphoproliferative Disorders trial results

Active, not recruiting

An Open-label, Phase 2 Study of ACP-196 in Subjects With Waldenström Macroglobulinemia

NCT02180724

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
Locations
  • Research Site Santa Barbara, California, United States
  • Research Site Aurora, Colorado, United States
  • Research Site Washington D.C., District of Columbia, United States
  • Research Site Minneapolis, Minnesota, United States
View all 38 locations
View Trial Details
Active, not recruiting

A Comparison of Three Chemotherapy Regimens for the Treatment of Patients With Newly Diagnosed Mantle Cell Lymphoma

NCT04115631

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations
  • Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
  • Anchorage Radiation Therapy Center Anchorage, Alaska, United States
  • Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States
  • Alaska Oncology and Hematology LLC Anchorage, Alaska, United States
View all 504 locations
View Trial Details
Active, not recruiting

A Study of Zanubrutinib Plus Anti-CD20 Versus Lenalidomide Plus Rituximab in Participants With Relapsed/Refractory Follicular or Marginal Zone Lymphoma

NCT05100862

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +11 more
Locations
  • Ucsf Fresno University of California San Francisco Fresno Fresno, California, United States
  • Kaiser Permanente Southern California Irvine, California, United States
  • Cancer and Blood Specialty Clinic Los Alamitos, California, United States
  • Los Angeles Cancer Network Los Angeles, California, United States
View all 264 locations
View Trial Details
Active, not recruiting

Study of Atezolizumab Plus BEGEV Regimen in Relapsed or Refractory Hodgkin's Lymphoma Patients

NCT05300282

Conditions
Disease Attributes, Hemic and Lymphatic Diseases, Hodgkin Disease, +11 more
Locations
  • S.C. Ematologia - A.O. SS. Antonio e Biagio e Cesare Arrigo Alessandria, Italy
  • Ematologia - Fondazione del Piemonte per l'Oncologia - IRCCS Candiolo, Turin, Italy
  • S.C. Ematologia e Trapianto emopoietico - Azienda Ospedaliera S.Giuseppe Moscati Avellino, Italy
  • Divisione di Oncologia e dei Tumori immuto-correlati - IRCCS Centro di Riferimento Oncologico di Aviano Aviano, Italy
View all 28 locations
View Trial Details
Active, not recruiting

A Pediatric and Young Adult Trial of Genetically Modified T Cells Directed Against CD22 for Relapsed/Refractory Leukemia or Lymphoma

NCT04571138

Conditions
Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +7 more
Locations
  • Children's Hospital Los Angeles Los Angeles, California, United States
  • Riley Hospital for Children Indianapolis, Indiana, United States
  • Texas Children's Hospital Houston, Texas, United States
  • Seattle Children's Hospital Seattle, Washington, United States
View Trial Details
Active, not recruiting

A Study Assessing Adverse Event and How Oral ABBV-453 Moves Through the Body in Adult Participants With Relapsed or Refractory (R/R) Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)

NCT06291220

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +15 more
Locations
  • City of Hope /ID# 253904 Duarte, California, United States
  • City of Hope - Orange County Lennar Foundation Cancer Center /ID# 267158 Irvine, California, United States
  • Duplicate_Duke Cancer Center /ID# 258707 Durham, North Carolina, United States
  • MD Anderson Cancer Center /ID# 253713 Houston, Texas, United States
View all 21 locations
View Trial Details

Related conditions